Amlodipine and Olmesartan Medoxomil Tablets
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets (10 mg/20 mg) due to failed dissolution specifications.
Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking your medication without consulting a medical professional.
Recall at a glance
- Quantity recalled
- 6,192 bottles
Why it was recalled
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets due to failed dissolution specifications and Olmesartan Medoxomil content that is below required specifications. This recall affects the 10 mg/20 mg strength in 30-count bottles.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Amlodipine and Olmesartan Medoxomil Tablets
- Lot code
- 25121311, 2028
- Strength
- 10 mg
- UPC
- 25121311
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Dissolution Failure recalls
Other recent recalls from Ascend Laboratories, LLC
Editorial summary by Recall Canary · summary updated 2026-07-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification